Ixabepilone plus capecitabine vs capecitabine in patients with triple negative tumors: a pooled analysis of patients from two large phase III clinical studies.
暂无分享,去创建一个
E. Perez | H. Rugo | H. Chung | G. Lerzo | H. Roché | E. Thomas | V. Poulart | K. Blackwell | La Volles